Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

8.72
+0.35004.18%
Pre-market: 9.150.4284+4.91%08:40 EDT
Volume:2.26M
Turnover:19.30M
Market Cap:935.00M
PE:-4.66
High:8.76
Open:8.62
Low:8.27
Close:8.37
52wk High:11.45
52wk Low:3.79
Shares:107.23M
Float Shares:64.81M
Volume Ratio:2.19
T/O Rate:3.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8709
EPS(LYR):-1.9922
ROE:-65.50%
ROA:-36.38%
PB:2.50
PE(LYR):-4.38

Loading ...

J.P. Morgan Reaffirms Their Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
May 23

Solid Biosciences Price Target Maintained With a $16.00/Share by Wedbush

Dow Jones
·
May 18

Wedbush Adjusts Price Target on Solid Biosciences to $16 From $17, Maintains Outperform Rating

MT Newswires Live
·
May 13

Solid Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 13

Wedbush Reaffirms Their Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
May 13

Solid Biosciences Q1 EPS $(0.52) Misses $(0.44) Estimate

Benzinga Earnings
·
May 13

Solid Biosciences Q1 net loss widens on higher R&D costs

Reuters
·
May 13

Press Release: Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 13

Solid Biosciences Q1 FY26 net loss widens 44.4% to $56.74 million

Reuters
·
May 13

Solid Biosciences Inc expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
May 11

Solid Biosciences doses part participant in IMPACT DUCHENNE study

TIPRANKS
·
May 08

Solid Biosciences doses first patient in Phase 3 SGT-003 Duchenne trial

Reuters
·
May 07

Solid Biosciences Doses First Participant in Phase 3 Impact Duchenne Clinical Trial Evaluating Sgt-003 in Duchenne Muscular Dystrophy

THOMSON REUTERS
·
May 07

Solid Biosciences grants 8,070 inducement RSUs to new hire under Nasdaq rule

Reuters
·
May 02

Solid Biosciences to present 16 abstracts at ASGCT annual meeting

Reuters
·
Apr 30

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

GlobeNewswire
·
Apr 30

Solid Biosciences receives orphan drug designation for SGT-003 from EC

TIPRANKS
·
Apr 28

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire
·
Apr 28

Barinthus Biotherapeutics appoints Douglas Swirsky as CFO effective May 1

Reuters
·
Apr 23

Solid Biosciences Adjusts Board Classes in Governance Move

TIPRANKS
·
Apr 11